August 26th 2025
Incannex Healthcare shared positive data from its phase 2 clinical trial of PSX-001, a psilocybin-assisted psychotherapy treatment for generalized anxiety disorder.
Psychiatrists Beware! The Impact of COVID-19 and Pandemics on Mental Health
March 15th 2020Psychiatrists are uniquely situated to help both their patients and the greater community understand the potential impact of the virus and help patients, families, and society deal with this latest threat.
Read More
Untangling the Web of Comorbid Obsessive-Compulsive Disorder and Medical Illness
OCD symptoms can be quite difficult to recognize. Not understanding what is happening, patients tend to be ashamed and suffer in silence, often resulting in a period of 8 to 10 years of untreated illness and long-term negative outcomes.
Read More
The Role of Psychiatrists During the Coronavirus Outbreak
March 4th 2020Emerging infectious disease outbreaks cause significant fear and uncertainty. Psychiatrists can play an important role in supporting the well-being of patients and families, health care personnel, and the general public.
Read More
7 Measures for Screening and Assessing IPV
January 28th 2020Data suggest that it is important for mental health professionals to screen for interpersonal violence and provide relevant treatment referrals. A selection of widely available and validated interpersonal violence screening measures are described in this slideshow.
Read More
5 Domains of Functional Assessment for Disability Evaluation
Problems with any one of these domains can disrupt an individual’s capacity to sustain work capacity.
Read More
How Anxiety and Habits Contribute to Anorexia Nervosa
September 30th 2019Anorexia nervosa (AN) is a severe and debilitating illness with one of the highest mortality rates of any psychiatric disorder. The illness course is often long, recovery is slow, and the rates of full recovery are low.
Read More